Top Markets
Coin of the day
Levitee Labs Inc. Levitee Labs Inc.

Levitee Labs Inc.

LVT
Rank in Stocks #39735
Headquartered in Vancouver, Canada, Levitee Labs Inc., established in 2019,... Headquartered in Vancouver, Canada, Levitee Labs Inc., established in 2019, functions as a comprehensive wellness enterprise. The company is dedicated to delivering evidence-backed alternative medical treatments and pioneering psychedelic therapies, operating through its Medical Services and Selling Products divisions. Within its medical operations, Levitee Labs provides care and prescriptions for a range of conditions, including substance use disorders, various chronic pain conditions such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome, in addition to Hepatitis-C and diverse mental health issues. This segment encompasses the management of five Levitee Clinics and three Levitee Pharmacies situated in Alberta. Furthermore, the company facilitates electronic prescriptions for addiction treatment via its BlockMD platform and distributes a selection of wholesale supplements and superfoods under the Earth Circle Organics brand. The organization adopted its current name, Levitee Labs Inc., on November 30, 2020, having previously been known as Fibonacci Capital Corp.
Share Price
$0.00366968
Last synced: 2024-07-23
Market Cap
$368.50K
Change (1 day)
-0.91%
Change (1 year)
0.00%
Country
CA
Trade Levitee Labs Inc. (LVT)

Category

Revenue for Levitee Labs Inc. (LVT)
Revenue in Aug 2026 TTM: 0
According to Levitee Labs Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Levitee Labs Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors